Company Filing History:
Years Active: 2022
Title: The Innovative Contributions of Peter Littlewood
Introduction
Peter Littlewood is a notable inventor based in Abingdon, GB. He has made significant contributions to the field of cancer treatment through his innovative research and patenting efforts. His work focuses on methods that combine DNA damaging agents with ATR inhibitors to effectively treat proliferative disorders.
Latest Patents
Peter Littlewood holds a patent for a method of treating cancer using a combination of DNA damaging agents and ATR inhibitors. This patent describes methods for treating a proliferative disorder, such as cancer, by administering a DNA damaging agent followed by an ATR protein kinase inhibitor within a specific time frame. The patent outlines exemplary ATR inhibitors represented by specific formulae, providing a detailed approach to cancer treatment.
Career Highlights
Peter Littlewood is currently associated with Vertex Pharmaceuticals, Inc., where he continues to advance his research in cancer therapies. His work has garnered attention for its potential to improve treatment outcomes for patients suffering from various forms of cancer.
Collaborations
Peter has collaborated with esteemed colleagues, including John Robert Pollard and Philip Michael Reaper, to further enhance the impact of his research in the pharmaceutical field.
Conclusion
Peter Littlewood's innovative approach to cancer treatment through his patented methods exemplifies the critical role of inventors in advancing medical science. His contributions are paving the way for more effective therapies in the fight against cancer.